These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 17224633)

  • 1. Disruption of the Fanconi anemia pathway in human cancer in the general population.
    Jacquemont C; Taniguchi T
    Cancer Biol Ther; 2006 Dec; 5(12):1637-9. PubMed ID: 17224633
    [No Abstract]   [Full Text] [Related]  

  • 2. Incidence of malignancy and clonal chromosomal abnormalities in Fanconi anemia.
    Vundinti BR; Korgaonkar S; Ghosh K
    Indian J Cancer; 2010; 47(4):397-9. PubMed ID: 21131752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fanconi Anemia Signaling and Cancer.
    Nepal M; Che R; Zhang J; Ma C; Fei P
    Trends Cancer; 2017 Dec; 3(12):840-856. PubMed ID: 29198440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer in Fanconi anemia, 1927-2001.
    Alter BP
    Cancer; 2003 Jan; 97(2):425-40. PubMed ID: 12518367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VACTERL with hydrocephalus: one end of the Fanconi anemia spectrum of anomalies?
    Porteous ME; Cross I; Burn J
    Am J Med Genet; 1992 Aug; 43(6):1032-4. PubMed ID: 1415330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acquisition of Relative Interstrand Crosslinker Resistance and PARP Inhibitor Sensitivity in Fanconi Anemia Head and Neck Cancers.
    Lombardi AJ; Hoskins EE; Foglesong GD; Wikenheiser-Brokamp KA; Wiesmüller L; Hanenberg H; Andreassen PR; Jacobs AJ; Olson SB; Keeble WW; Hays LE; Wells SI
    Clin Cancer Res; 2015 Apr; 21(8):1962-72. PubMed ID: 25609062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignant disease in heterozygous carriers.
    Swift M
    Birth Defects Orig Artic Ser; 1976; 12(1):133-44. PubMed ID: 990439
    [No Abstract]   [Full Text] [Related]  

  • 8. Connecting Fanconi anemia to BRCA1.
    Joenje H; Arwert F
    Nat Med; 2001 Apr; 7(4):406-7. PubMed ID: 11283658
    [No Abstract]   [Full Text] [Related]  

  • 9. Squamous cell carcinoma of the vulva and Fanconi anemia.
    Arnold WJ; King CR; Magrina J; Masterson BJ
    Int J Gynaecol Obstet; 1980; 18(6):395-7. PubMed ID: 6111473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Head and neck squamous cell carcinoma in patients with Fanconi anemia.
    Van Waes C
    Arch Otolaryngol Head Neck Surg; 2005 Jul; 131(7):640-1. PubMed ID: 16027290
    [No Abstract]   [Full Text] [Related]  

  • 11. Reassessment of cancer predisposition of Fanconi anemia heterozygotes.
    Swift M; Caldwell RJ; Chase C
    J Natl Cancer Inst; 1980 Nov; 65(5):863-7. PubMed ID: 6933255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promoter hypermethylation of FANCF: disruption of Fanconi Anemia-BRCA pathway in cervical cancer.
    Narayan G; Arias-Pulido H; Nandula SV; Basso K; Sugirtharaj DD; Vargas H; Mansukhani M; Villella J; Meyer L; Schneider A; Gissmann L; Dürst M; Pothuri B; Murty VV
    Cancer Res; 2004 May; 64(9):2994-7. PubMed ID: 15126331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fanconi anemia: adult head and neck cancer and hematopoietic mosaicism.
    Alter BP; Joenje H; Oostra AB; Pals G
    Arch Otolaryngol Head Neck Surg; 2005 Jul; 131(7):635-9. PubMed ID: 16027289
    [No Abstract]   [Full Text] [Related]  

  • 14. [Congenital aplastic anemia (constitutional, hereditary) Fanconi type].
    Vuković I; Stojimirović E; Ajdarić B; Jovanović M
    Srp Arh Celok Lek; 1974 Sep; 102(9):651-4. PubMed ID: 4465937
    [No Abstract]   [Full Text] [Related]  

  • 15. The Fanconi Anemia Pathway and Fertility.
    Tsui V; Crismani W
    Trends Genet; 2019 Mar; 35(3):199-214. PubMed ID: 30683429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The molecular and cellular biology of Fanconi anemia.
    Garcia-Higuera I; Kuang Y; D'Andrea AD
    Curr Opin Hematol; 1999 Mar; 6(2):83-8. PubMed ID: 10088637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fanconi anemia-associated signature in cancer.
    Danovi S
    Nat Genet; 2023 Jan; 55(1):1. PubMed ID: 36639507
    [No Abstract]   [Full Text] [Related]  

  • 18. Fanconi anaemia: genetics, molecular biology, and cancer – implications for clinical management in children and adults.
    Schneider M; Chandler K; Tischkowitz M; Meyer S
    Clin Genet; 2015 Jul; 88(1):13-24. PubMed ID: 25307146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fanconi anemia leading to acute myelomonocytic leukemia: cytogenetic studies.
    Bourgeois CA; Hill FG
    Cancer; 1977 Mar; 39(3):1163-7. PubMed ID: 269749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolated glycerol kinase deficiency and Fanconi anemia.
    Sjarif DR; Révész T; de Koning TJ; Duran M; Beemer FA; Poll-The BT
    Am J Med Genet; 2001 Mar; 99(2):159-60. PubMed ID: 11241478
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.